Search results
Found 22802 matches for
Oswaldo Cruz Foundation (Fiocruz) is a leading institution of science and a public health in Latin America. The new online knowledge hub launched on 3rd December 2019 and feature virtual courses, information and news about the Foundation.
Strengthening Pharmacy resilience in public health crises in Nigeria
23 February 2026
Dr Rachel Obonose Titus developed evidence-based Standard Operating Procedures (SOPs) to strengthen Nigerian community pharmacies during public health emergencies. Inspired by COVID-19 challenges, her work translates frontline experiences into practical policy tools. Through an AfOx Visiting Fellowship, she advanced evaluation and stakeholder engagement, aiming for national adoption and improved health system resilience.
My mission is to strengthen women’s futures in Congo and Africa through education and partnerships
20 February 2026
Sarah Mugoli Balekage’s journey from the Democratic Republic of Congo to Oxford University is driven by faith and a commitment to empowering women through education. An Africa Oxford Initiative Scholar, she is pursuing African studies to advance social entrepreneurship and community advocacy, aiming to promote unity, development and opportunity across Africa.
New Study highlights demographic shift of visceral leishmaniasis to older patients and increased incidence of relapses in Brazil
18 February 2026
A new study into visceral leishmaniasis (VL) in Brazil has created the most comprehensive picture of the disease in the country, and highlighted trends including more older patients being diagnosed with the disease and more patients presenting with relapses over time.
Identifying fake vaccines and insulin using hospital analysers
17 February 2026
The Medicine Quality Research Group is part of the collaboration which has demonstrated that hospital analysers can be used to identify fake liquid medical products. This low-cost, accessible approach offers a promising tool for global health systems to protect patients, particularly in low-resource settings.
IHTM Introduces New Pandemic Sciences Module
16 February 2026
Developing Skills for Pandemic Preparedness
EQUIPSEA: Recognising the people behind-the-science
13 February 2026
Behind every research breakthrough are people managing the grants, budgets, and partnerships that make the work possible. At OUCRU in February 2026, EQUIPSEA brought together 75 research management professionals from across Southeast Asia for one of the region’s first professional training programmes designed specifically for them.
‘Peer power’ transforming HIV testing among fishing communities in Uganda
9 February 2026
In Uganda’s fishing communities, Dr Joseph Matovu is leading a peer-led HIV self-testing project to overcome stigma and healthcare access barriers. With support from the Africa Oxford Initiative (AfOx), the PEST4MEN model empowers local leaders to distribute self-test kits, improving uptake, linkage to care, and community ownership of HIV prevention.
Professor Sir Nicholas White OBE KCMG FRS
3 February 2026
The Centre for Tropical Medicine and Global Health, the University of Oxford and the Nuffield Department of Medicine greatly mourn the death of Professor Sir Nicholas White, a distinguished clinician and scientist who was internationally recognised as the leading figure in improving the treatment of malaria worldwide, and whose work has made a lasting contribution to global health research - saving millions of lives worldwide. Our thoughts are with his family at this time.
OUCRU & the Hospital for Tropical Diseases: 35 years of partnership
2 February 2026
From our earliest malaria trials in 1991 to today’s shared work on many infectious diseases, OUCRU marks 35 years of partnership with the Hospital for Tropical Diseases in Ho Chi Minh City, Vietnam, advancing research that improves patient care and strengthens responses to infectious diseases. Rooted in frontline clinical collaboration, OUCRU continues to drive evidence-based innovations, build local research capacity, and address evolving health challenges across Vietnam and the region.
Back by popular demand: The AMR Circus!
30 January 2026
Following the success of the Antimicrobial Resistance (AMR) Circus in Cambodia during May 2025, the Phare Ponleu Selpak (Brightness of the Arts) School students were back with new performances in Jan 2026.
Deirdre Hollingsworth among the first Fellows of the Academy for the Mathematical Sciences
30 January 2026
Professor Deirdre Hollingsworth is among twelve Oxford academics appointed to the Academy for the Mathematical Sciences’ inaugural cohort of Fellows, which will bring together the UK’s strongest mathematicians across academia, education, business, industry, and government to help solve some of the UK’s biggest challenges.
AMR Kenya 2026 Conference: Working Together to Tackle Antimicrobial Resistance
30 January 2026
The AMR Kenya 2026 Conference convened stakeholders across sectors to address the growing threat of antimicrobial resistance (AMR) in Kenya and the region. Under the theme “Working Together to Tackle AMR in Kenya,” participants co-developed practical solutions, highlighting the need for robust systems, data, stewardship, and local leadership. Interactive sessions addressed diagnostics, One Health, vaccines, and infection control. The conference concluded with a call for African-led, locally grounded responses and sustained investment to protect antimicrobial effectiveness and public health.
New interactive tool to assess devices for detecting substandard medicines
23 January 2026
The Medicine Quality Research Group has launched DAFODIL, a new digital platform to help regulators assess portable devices for detecting substandard and falsified medicines. Poor-quality medicines, responsible for serious health risks, remain a major issue globally. DAFODIL compiles available scientific evidence to enable comparisons of medication screening devices, supporting informed decision-making. Developed with input from regulators and funded by the Gates Foundation, the tool aims to strengthen global medicine quality surveillance and response.
“AMR Ambassador” Competition: When Students Become Voices Against Antimicrobial Resistance
23 January 2026
The OUCRU Hanoi Research Team and the PCE team, in collaboration with the Students’ Clinical Pharmacy Club, Hanoi University of Pharmacy successfully conducted the AMR Ambassador Competition on Monday, 12 January 2026, at Kim Lien High School, Hanoi.
IHTM students debate at Oxford Union
15 January 2026
Putting months of debate training into practice
OUCRU’s LAST ACT trial explores personalised treatment for tuberculous meningitis
15 January 2026
OUCRU’s LAST ACT trial, published in Nature Medicine, is the first tuberculosis study to assess treatment based on host genetics. The trial tested whether dexamethasone could be withheld in patients with low- or medium-inflammatory LTA4H genotypes. Results showed no evidence that placebo was as effective as dexamethasone, which remained safe and modestly effective across genotypes. These findings support continued use of dexamethasone and highlight the need for better-targeted treatments for tuberculous meningitis.
Oxford licenses Rift Valley fever vaccine candidate amid West Africa outbreak
13 January 2026
The University of Oxford has licensed an investigational Rift Valley fever vaccine candidate to the Serum Institute of India (SII) as outbreaks of the disease continue in parts of West Africa. Professor George Warimwe leads the development of the ChAdOx1 RVF vaccine, now progressing from lab to field use. The initiative enables rapid vaccine production and testing, offering hope for controlling this neglected zoonotic disease.
New Beginnings
12 January 2026
A look back at first-term activities as Hilary Term begins for the 2025/26 IHTM cohort
Francois Nosten on Fever Pitch podcast, on a collapsing border where medicine meets war
6 January 2026
Professor Francois Nosten, Director of MORU's Shoklo Malaria Research Unit (SMRU), reflects on the decades he’s spent on the border between Thailand and Myanmar, a place of relentless upheaval and quiet endurance. From the 1980s onward, he has lived amid war, displacement, and disease, building a fragile bridge between science and survival. He characterizes the border as a wound that never quite closes – people cross not for opportunity but to escape a state that devours its own. What he describes is not steady progress but a cycle of collapse and recovery, every advance shadowed by the return of violence and the onset of disease.
Professor Nicholas Day Honoured for Services to Global Health
6 January 2026
Professor Nicholas Day has been appointed Companion of the Order of St Michael and St George (CMG) for his outstanding contributions to global health research in the Kings New Years Honours 2026. With a career spanning over three decades at OUCRU and MORU, his leadership in infectious disease research has significantly advanced health equity in low-resource settings.